TRIN Stock Analysis: Trinity Capital | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 1.612m USD | 12M Return: 35.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 18.3M
EPS Trend: -80.9%
Qual. Beats: 1
Rev. Trend: 96.4%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 5.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Trinity Capital Inc. (TRIN) is a Phoenix-based business development company (BDC) founded in 2008 that provides debt financing to growth-stage companies across a wide range of industries. Its core offerings include term loans, equipment financing, and private credit investments, with activity spanning sectors such as aerospace, software, life sciences, clean technology, semiconductors, robotics, and consumer and retail. The firm operates as a BDC, a regulated investment vehicle required to invest primarily in private or thinly traded U.S. companies, making it a participant in the private credit market rather than traditional banking.
Headquartered in Phoenix with additional offices in Solana Beach and San Diego, Trinity Capital went public on NASDAQ on January 29, 2021. The company sits within the Financials sector and the Asset Management & Custody Banks sub-industry, and markets itself as an industry-agnostic lender targeting venture-backed and growth-oriented businesses. As a BDC, it is generally structured to distribute most of its taxable income to shareholders, positioning its common stock as a yield-oriented vehicle for investors seeking access to private credit returns.
- Floating-rate loan portfolio margins expand with elevated rate environment
- Origination activity accelerates in tech and life sciences lending verticals
- Credit quality deteriorates as non-accruals rise in growth-stage portfolio
- Private credit competition intensifies from direct lenders and alternative managers
| Net Income: 154.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA 12.98 > 1.0 |
| NWC/Revenue: 13.15% < 20% (prev -3.17%; Δ 16.32% < -1%) |
| CFO/TA -0.03 > 3% & CFO -79.4m > Net Income 154.0m |
| Net Debt (1.34b) to EBITDA (157.1m): 8.52 < 3 |
| Current Ratio: 26.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (83.6m) vs 12m ago 33.71% < -2% |
| Gross Margin: 81.52% > 18% (prev 74.05%; Δ 7.47% > 0.5%) |
| Asset Turnover: 12.51% > 50% (prev 12.85%; Δ -0.34% > 0%) |
| Interest Coverage Ratio: 2.25 > 6 (EBIT TTM 195.4m / Interest Expense TTM 87.0m) |
| A: 0.01 (Total Current Assets 37.7m - Total Current Liabilities 1.40m) / Total Assets 2.56b |
| B: -0.01 (Retained Earnings -19.3m / Total Assets 2.56b) |
| C: 0.09 (EBIT TTM 195.4m / Avg Total Assets 2.21b) |
| D: 0.84 (Book Value of Equity 1.17b / Total Liabilities 1.39b) |
| Altman-Z'' = 1.54 = BB |
As of July 28, 2026, the stock is trading at USD 17.41 with a total of 681,631 shares traded. Over the past week, the price has changed by -1.58%, over one month by -0.85%, over three months by +12.73% and over the past year by +35.18%.
Current recommended Stop Loss: 16.90 (which is 2.9% or 1.5 ATR below the current price).
Trinity Capital has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy TRIN.
- StrongBuy: 6
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 17.8 | 2.1% |
P/E Trailing = 9.3385
P/E Forward = 8.5251
P/S = 5.3694
P/B = 1.3634
P/EG = 5.1395
Revenue TTM = 276.0m USD
EBIT TTM = 195.4m USD
EBITDA TTM = 157.1m USD
Long Term Debt = 1.36b USD (estimated: total debt 1.36b - short term 1.40m)
Short Term Debt = 1.40m USD (from shortTermDebt, last quarter)
Debt = 1.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.34b USD (calculated: Debt 1.36b - CCE 19.6m)
Enterprise Value = 2.95b USD (1.61b + Debt 1.36b - CCE 19.6m)
Interest Coverage Ratio = 2.25 (Ebit TTM 195.4m / Interest Expense TTM 87.0m)
EV/FCF = -36.75x (Enterprise Value 2.95b / FCF TTM -80.3m)
FCF Yield = -2.72% (FCF TTM -80.3m / Enterprise Value 2.95b)
FCF Margin = -29.08% (FCF TTM -80.3m / Revenue TTM 276.0m)
Net Margin = 55.80% (Net Income TTM 154.0m / Revenue TTM 276.0m)
Gross Margin = 81.52% ((Revenue TTM 276.0m - Cost of Revenue TTM 51.0m) / Revenue TTM)
Gross Margin QoQ = 79.27% (prev none%)
Tobins Q-Ratio = 1.15 (Enterprise Value 2.95b / Total Assets 2.56b)
Interest Expense / Debt = 6.41% (Interest Expense 87.0m / Debt 1.36b)
Taxrate = 1.94% (3.01m / 155.3m)
NOPAT = 191.6m (EBIT 195.4m * (1 - 1.94%))
Current Ratio = 26.89 (Total Current Assets 37.7m / Total Current Liabilities 1.40m)
Debt / Equity = 1.16 (Debt 1.36b / totalStockholderEquity, last quarter 1.17b)
Debt / EBITDA = 8.52 (Net Debt 1.34b / EBITDA 157.1m)
Debt / FCF = -16.67 (negative FCF - burning cash) (Net Debt 1.34b / FCF TTM -80.3m)
Total Stockholder Equity = 1.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.98% (Net Income 154.0m / Total Assets 2.56b)
RoE = 14.73% (Net Income TTM 154.0m / Total Stockholder Equity 1.05b)
RoCE = 8.13% (EBIT 195.4m / Capital Employed (Equity 1.05b + L.T.Debt 1.36b))
RoIC = 7.54% (NOPAT 191.6m / Invested Capital 2.54b)
WACC = 7.14% (E(1.61b)/V(2.97b) * Re(7.86%) + D(1.36b)/V(2.97b) * Rd(6.41%) * (1-Tc(0.02)))
Discount Rate = 7.86% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 98.43 | Cagr: 27.87%
[DCF] Fair Price = unknown (Cash Flow -80.3m)
EPS Correlation: -80.90 | EPS CAGR: -1.93% | SUE: 1.25 | # QB: 1
Revenue Correlation: 96.36 | Revenue CAGR: 33.98% | SUE: -0.09 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.52 | Chg30d=-0.02% | Revisions=+12% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.52 | Chg30d=-0.21% | Revisions=+0% | Analysts=8
EPS current Year (2026-12-31): EPS=2.09 | Chg30d=+0.00% | Revisions=+44% | GrowthEPS=+0.5% | GrowthRev=+27.3%
EPS next Year (2027-12-31): EPS=2.07 | Chg30d=-0.67% | Revisions=+0% | GrowthEPS=-0.9% | GrowthRev=+10.6%
[Analyst] Revisions Ratio: +19% (up=14, down=9)